ENSKBio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

ENSKBio General Information

Description

Provider of cell therapy solutions designed to advance stem cell innovation in medicine. The company applies cell therapy technology to drug development for chronic diseases such as diabetes and collaborates with leading tertiary hospitals on clinical applications.

Contact Information

Website
www.enskbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Shazhou Lake Science and Technology Park
  • Number 188 Huachang Road, Zhangjiagang
  • Suzhou, Jiangsu
  • China
+86 0512
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Shazhou Lake Science and Technology Park
  • Number 188 Huachang Road, Zhangjiagang
  • Suzhou, Jiangsu
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ENSKBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 30-Mar-2026 Completed Generating Revenue
1. Early Stage VC 01-Sep-2025 Completed Generating Revenue
To view ENSKBio’s complete valuation and funding history, request access »

ENSKBio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Suzhou Xinrui Venture Capital Partnership Growth/Expansion Minority
Shanghai Biomedical Public Technology Corporation Minority
Zhangjiagang Jintai Jinhong Investment Management Growth/Expansion Minority
To view ENSKBio’s complete investors history, request access »

ENSKBio FAQs

  • When was ENSKBio founded?

    ENSKBio was founded in 2022.

  • Where is ENSKBio headquartered?

    ENSKBio is headquartered in Suzhou, China.

  • What industry is ENSKBio in?

    ENSKBio’s primary industry is Drug Discovery.

  • Is ENSKBio a private or public company?

    ENSKBio is a Private company.

  • What is ENSKBio’s current revenue?

    The current revenue for ENSKBio is .

  • Who are ENSKBio’s investors?

    Suzhou Xinrui Venture Capital Partnership, Shanghai Biomedical Public Technology, and Zhangjiagang Jintai Jinhong Investment Management have invested in ENSKBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process